BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 11916240)

  • 1. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
    Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
    Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
    Ugai S; Shimozato O; Kawamura K; Wang YQ; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
    Chiyo M; Shimozato O; Iizasa T; Fujisawa T; Tagawa M
    Anticancer Res; 2004; 24(6):3763-7. PubMed ID: 15736409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
    Imai H; Saio M; Nonaka K; Suwa T; Umemura N; Ouyang GF; Nakagawa J; Tomita H; Osada S; Sugiyama Y; Adachi Y; Takami T
    Cancer Sci; 2007 Mar; 98(3):416-23. PubMed ID: 17270031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
    Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
    Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
    Tasaki K; Gunji Y; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S; Tagawa M
    Anticancer Res; 1998; 18(3A):1453-6. PubMed ID: 9673355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
    Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
    Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
    Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.
    Shan BE; Hao JS; Li QX; Tagawa M
    Cell Mol Immunol; 2006 Feb; 3(1):47-52. PubMed ID: 16549049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.
    Kawamura K; Tasaki K; Hamada H; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Apr; 7(4):637-43. PubMed ID: 10811483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
    Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells.
    Yoshida Y; Tasaki K; Kimurai M; Takenaga K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Anticancer Res; 1998; 18(1A):333-5. PubMed ID: 9568099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
    Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
    Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
    Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.
    Nakamori M; Iwahashi M; Nakamura M; Ueda K; Zhang X; Yamaue H
    Clin Cancer Res; 2003 Jun; 9(6):2357-65. PubMed ID: 12796406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
    Gunji Y; Tasaki K; Tagawa M; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Sakiyama S
    Cancer Gene Ther; 1998; 5(6):339-43. PubMed ID: 9917087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.